Intraductal Carcinoma — Trials

Intraductal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 31
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (29)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02876640	Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer	terminated	Phase 1	27	National Cancer Institute (NCI)NIH	1	Jun 18, 2024	clinicaltrials
NCT02365714	CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)(CK-SAPBI)	terminated	Phase 1 / Phase 2	2	Georgetown UniversityOTHER	1	Apr 13, 2018	clinicaltrials